Orthofix Medical (OFIX) Cost of Revenue (2010 - 2026)

Orthofix Medical (OFIX) has reported Cost of Revenue for 17 consecutive years, with $61.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cost of Revenue fell 3.71% year-over-year to $61.2 million; the trailing twelve-month figure through Jun 2026 stood at $239.1 million (down 9.44% YoY), and the FY2025 full-year result was $256.3 million, up 1.06% from the prior year.
• Cost of Revenue was $61.2 million for Q2 2026 at Orthofix Medical, up from $57.2 million in the prior quarter.
• The five-year high for Cost of Revenue was $72.0 million in Q1 2025, with the low at $28.3 million in Q1 2022.
• Historically, Cost of Revenue has averaged $56.2 million across 5 years, with a median of $62.6 million in 2024.
• Annual changes were most pronounced in 2023 — Cost of Revenue jumped 129.09% — and 2026, when it declined 20.64%.
• Tracing OFIX's Cost of Revenue over 5 years: stood at $33.1 million in 2022, then surged by 92.98% to $63.8 million in 2023, then gained by 4.75% to $66.8 million in 2024, then decreased by 4.86% to $63.6 million in 2025, then decreased by 3.69% to $61.2 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $61.2 million in Q2 2026, $57.2 million in Q1 2026, and $63.6 million in Q4 2025.